XML 12 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Condensed Consolidated Balance Sheets (unaudited) - USD ($)
$ in Millions
Sep. 30, 2022
Dec. 31, 2021
Current assets:    
Cash and cash equivalents $ 1,601 $ 2,951
Accounts receivable, net of allowances of $120 in 2022 and $122 in 2021 2,555 2,629
Inventories 2,675 2,453
Prepaid expenses and other current assets 979 839
Total current assets 7,810 8,872
Property, plant and equipment, net 4,799 5,178
Goodwill 6,639 9,836
Other intangible assets, net 6,927 7,792
Operating lease right-of-use assets 546 630
Other non-current assets 1,244 1,213
Total assets 27,965 33,521
Current liabilities:    
Short-term debt 275 301
Current maturities of long-term debt and finance lease obligations 4 210
Accounts payable 1,234 1,246
Accrued expenses and other current liabilities 2,195 2,479
Total current liabilities 3,708 4,236
Long-term debt and finance lease obligations, less current portion 16,153 17,149
Operating lease liabilities 454 522
Other non-current liabilities 2,071 2,493
Total liabilities 22,386 24,400
Commitments and contingencies
Equity:    
Common stock, $1 par value, authorized 2,000,000,000 shares, issued 683,494,944 shares in 2022 and 2021 683 683
Common stock in treasury, at cost,179,451,293 shares in 2022 and 181,879,516 shares in 2021 (11,406) (11,488)
Additional contributed capital 6,297 6,197
Retained earnings 14,015 17,065
Accumulated other comprehensive income (loss) (4,054) (3,380)
Total Baxter stockholders’ equity 5,535 9,077
Noncontrolling interests 44 44
Total equity 5,579 9,121
Total liabilities and equity $ 27,965 $ 33,521